ts-one od tablet 20
zuellig pharma sdn bhd - tegafur; gimeracil; oteracil potassium -
ts-one od tablet 25
zuellig pharma sdn bhd - oteracil potassium; tegafur; gimeracil -
ts-one od tablet 20
zuellig pharma sdn bhd - tegafur; gimeracil; oteracil potassium -
ts-one od tablet 25
zuellig pharma sdn bhd - tegafur; gimeracil; oteracil potassium -
ts-one capsule 20
taiho pharma asia pacific pte. ltd. - gimeracil; oteracil potassium; tegafur - capsule - 5.8mg - gimeracil 5.8mg; oteracil potassium 19.6mg; tegafur 20mg
ts-one capsule 25
taiho pharma asia pacific pte. ltd. - gimeracil; oteracil potassium; tegafur - capsule - 7.25mg - gimeracil 7.25mg; oteracil potassium 24.5mg; tegafur 25mg
teysuno 20mg5.8mg15.8mg capsules
nordic pharma ltd - tegafur; gimeracil; oteracil potassium - capsule - 20mg ; 5.8mg ; 15.8mg
teysuno 15mg4.35mg11.8mg capsules
nordic pharma ltd - tegafur; gimeracil; oteracil potassium - capsule - 15mg ; 4.35mg ; 11.8mg
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - stomach neoplasms - antineoplastic agents - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5.1).- as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
ts-one capsule 20
dksh malaysia sdn bhd - tegafur; gimeracil; oteracil potassium -